Hakob Atshemyan

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Médecins Sans Frontières(Current)

Harvard University

Brigham and Women's Hospital

Interactive Research and Development

Partners In Health

Hakob Atshemyan is an author at Médecins Sans Frontières specializing in tuberculosis control, multidrug-resistant tuberculosis treatment, and pharmacotherapy.

ORCID

Publications per year

2018–2021

Publications

Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study

Molly F. Franke, Palwasha Khan, Cathy Hewison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 55 citations · Full text

Public Health, Pharmacotherapy, Clinical Pharmacology +13

High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study

Helena Huerga, Elisabeth Sánchez-Padilla, Nara Melikyan et al. · Archives of Disease in Childhood · 2018 · 21 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe

Nara Melikyan, Helena Huerga, Hakob Atshemyan et al. · Open Forum Infectious Diseases · 2021 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Setting up pharmacovigilance based on available endTB Project data for bedaquiline

Nathalie Lachenal, Catherine Hewison, Carole D. Mitnick et al. · The International Journal of Tuberculosis and Lung Disease · 2020 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–4 of 4